Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome
Camille Le Breton(Hôpital Louis-Mourier), Damien Roux(Inserm), Constance Vuillard(Hôpital Louis-Mourier), Jean-Damien Ricard(Inserm), Noémie Zucman(Université Paris Cité), Laura Federici(Hôpital Louis-Mourier), Baptiste Gaborieau(Centre National de la Recherche Scientifique), Dan Longrois(Hôpital Bichat-Claude-Bernard), Pierre Postel-Vinay(Hôpital Louis-Mourier), Melissa Dominicé Dao(Hôpital Louis-Mourier), Alain Combes(Sorbonne Université), Marc Amouretti(Hôpital Louis-Mourier), Santiago Freita-Ramos(Hôpital Louis-Mourier), L. Dumont(Université Paris Cité), Didier Dreyfuss(Inserm), Sébastien Besset(Hôpital Louis-Mourier), Pierre Antoine Billiet(Inserm), Guillaume Lebreton(Inserm)
Cited by 32
Related Papers
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
|JAMA|2020|518
Comfort and patient-centred care without excessive sedation: the eCASH concept
|Intensive Care Medicine|2016|429
The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline
|Intensive Care Medicine|2020|413